QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (39) Citing Articles via Google Scholar Google Scholar Articles by Jentsch, J. D. Articles by Roth, R. H. Search for Related Content PubMed PubMed Citation Articles by Jentsch, J. D. Articles by Roth, R. H.

 Previous Article  |  Next Article 

Volume 17, Number 5, Issue of March 1, 1997 pp. 1769-1775
Copyright ©1997 Society for Neuroscience

Phencyclidine Increases Forebrain Monoamine Metabolism in Rats and Monkeys: Modulation by the Isomers of HA966

Received Oct. 11, 1996; revised Dec. 5, 1996; accepted Dec. 9, 1996.

J. David Jentsch¹, John D. Elsworth^{2, 3}, D. Eugene Redmond Jr.^{2, 4}, and Robert H. Roth^{2, 3}

Departments of ¹ Neurobiology, ² Psychiatry, ³ Pharmacology, and ⁴ Neurosurgery, Yale University School of Medicine, New Haven, Connecticut 06510

The noncompetitive NMDA receptor antagonist phencyclidine (PCP) has psychotomimetic properties in humans and activates the frontal cortical dopamine innervation in rats, findings that have contributed to a hyperdopaminergic hypothesis of schizophrenia. In the present studies, the effects of the enantiomers of 3-amino-1-hydroxypyrrolid-2-one (HA966) on PCP-induced changes in monoamine metabolism in the forebrain of rats and monkeys were examined, because HA966 has been shown previously to attenuate stress- or drug-induced activation of dopamine systems. In rats, PCP (10 mg/kg, i.p.) potently activated dopamine (DA) turnover in the medial prefrontal cortex (PFC) and nucleus accumbens. Serotonin utilization was also increased in PFC. Pretreatment with either R-(+)HA966 (15 mg/kg, i.p.) or S-()HA966 (3 mg/kg, i.p.) partially blocked PCP-induced increases in PFC DA turnover, whereas neither enantiomer altered the effect of PCP on DA turnover in the nucleus accumbens or the PCP-induced increases in serotonin turnover in PFC. PCP (0.3 mg/kg, i.m.) exerted regionally selective effects on the dopaminergic and serotonergic innervation of the monkey frontal cortex, effects blocked by pretreatment with S-()HA966 (3 mg/kg, i.m.). Importantly, these data demonstrate that in the primate, PCP has potent effects on dopamine transmission in the frontal cortex, a brain region thought to be dysfunctional in schizophrenia. In addition, a role for S-()HA966 as a modulator of cortical monoamine transmission in primates is posited.

Key words: dopamine; HA966; monkey; phencyclidine; prefrontal cortex; psychotomimetic; rat; schizophrenia; serotonin; turnover

This article has been cited by other articles:

				Y. Dong, F. J. Nasif, J. J. Tsui, W. Y. Ju, D. C. Cooper, X.-T. Hu, R. C. Malenka, and F. J. White Cocaine-Induced Plasticity of Intrinsic Membrane Properties in Prefrontal Cortex Pyramidal Neurons: Adaptations in Potassium Currents J. Neurosci., January 26, 2005; 25(4): 936 - 940. [Abstract] [Full Text] [PDF]

				J. D. Jentsch, D. E. Redmond Jr., J. D. Elsworth, J. R. Taylor, K. D. Youngren, and R. H. Roth Enduring Cognitive Deficits and Cortical Dopamine Dysfunction in Monkeys After Long-Term Administration of Phencyclidine Science, August 15, 1997; 277(5328): 953 - 955. [Abstract] [Full Text]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help